Novel nanoparticle SARS-CoV-2 vaccine combines immune focusing and self-assembling nanoparticles to elicit more potent protection

First generation COVID-19 vaccines have been highly effective, but also have limitations. Now, scientists have developed a more targeted vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.